Overview

A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults

Status:
Completed
Trial end date:
2014-03-24
Target enrollment:
Participant gender:
Summary
This was single-center, open-label, randomized, 3-period, 3-treatment, 6-sequence crossover study evaluating the PK of single doses of WTX101 in healthy participants based on the measurement of plasma total Molybdenum.
Phase:
Phase 1
Details
Lead Sponsor:
Alexion Pharmaceuticals
Treatments:
Choline
Omeprazole
Tetrathiomolybdate